Psoriasis is a non-contagious common skin condition that causes rapid skin cell reproduction that results in red, dry patches of thickened or scaly skin commonly affecting the elbows, knees, back and scalp.
Psoriasis symptoms can range from mild to severe where the entire body is virtually covered in thick red scaly skin. Psoriasis is a chronic, non-curable skin condition that can periodically improve and worsen. Some people notice psoriasis conditions worsen with cold dry weather and improve with warmer months and increased sun exposure, In some cases, people can even experience psoriasis remission for years.
Psoriasis affects all races and sexes worldwide and currently affects about 8 million people in the USA. It is an autoimmune condition that is often diagnosed in young adulthood.
MD Claiborne Dermatology is one of the few practices to offer full-body narrow band ultraviolet B (nbUVB) phototherapy treatment as a non-immunosuppressive treatment option for plaque psoriasis. For moderate to severe psoriasis, we use highly effective advanced biologics therapies to calm the overactive immune system.
There are three main types of biologics available:
1. Anti-TNFs (Humira/Enbrel/Remicade/Cimzia)
2. Anti-IL17s (Cosentyx/Taltz/Siliq)
3. Anti-IL23s (Skyrizi/Tremfya)
Drs. Martin and Cole Claiborne specialize in the treatment of psoriasis and have an ongoing clinical trial for psoriasis sponsored by U Penn and the National Psoriasis Foundation.